Altered immunoglobulin concentrations and light chain ratios in juvenile onset mixed connective tissue disease by Haraldsson, A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/20445
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Clinical rheumatology, 1995,14, N° 1 51-54
Altered Immunoglobulin Concentrations and Light 
Chain Ratios in Juvenile Onset Mixed Connective 
Tissue Disease
A . H A R A L D S S O N *  H L A . W>M, T I D D E N S * ,  T. F I S E L I E R ,  J . A J . M ,  B A K K E R E N ,
C . M . R .  W E E M A E S
Immunological disturbances may result in altered immunoglobulin 
concentrations and kappa/lainbda light chain (k/X) ratios. We measured the k/X 
ratios of total serum immunoglobulins and of polyclonal IgG, A, and M separately 
as well as concentrations of these immunoglobulins in fourteen patients with juve­
nile onset mixed connective tissue disease. When comparing the patient group with 
a reference group the mean serum IgG and IgA concentrations were respectively 
2.98 G/L (p=0.0012) and 0.79 G/L (p=0.0114) higher in the group of patients with 
juvenile onset mixed connective tissue disease. The mean IgM concentration was 
0,39 G/L (p = 0.0002) lower.
The mean k/X ratios of total serum immunoglobulins, serum IgG, and serum IgA 
were respectively 0.20 (p=0.0226), 0.28 (p~0.0016) and 0.10 (p=0.0732), higher 
in the group of patients with mixed connective tissue disease as compared with the 
reference group. M ean serum IgM k/X ratio, however, was 0.21 ( p = 0.0046) lower. 
The alterations of the serum immunoglobulin concentrations and of the k/X ratios 
reflect immunological disturbances in patients with juvenile onset mixed connec­
tive tissue disease. The increased concentration of serum IgG and raised IgG k/X 
ra tio  and decreased concentration of serum IgM with decreased IgM K/X ratio in­
dicate tha t the synthesis of K-bearing immunoglobulins mainly is affected.
Key words Mixed Connective Tissue Disease, Immunoglobulin 
Concentration, Immunoglobulin Light Chains.
IN T R O D U C T IO N  described in juvenile chronic arthritis (8). Genetic stud­
ies have indicated that certain light chain genotypes may
Mixed connective tissue disease (MCTD) is, although increase the risk of developing rheumatoid arthritis in
debated, recognized as a distinct; clinical entity within the adults (9,10). Evidence has been provided in animal stud-
group of connective tissue diseases (1). The clinical man- ies that autoanlibodies can he elicited by injecting puri-
ifestations can resemble those of systemic lupus erythe- fied light chains from a lupus-prone mouse into normal
matosus (SLE), progressive systemic sclerosis and poly- mice (11). IgGvc paraproteins have also been found to
myositis/dermatomyositis (1-3). Anti-ribonucleoprotein causc arthritis in humans (12).
(RNP) antibodies are usually present (1-3). Juvenile on- In view of the altered light chain ratios in some au-
set MCTD shows many similarities to the adult form (4). toimmune disorders, we studied the k/X ratios in juve- 
The immunoglobulin k  and X light chain ratios are al~ nile onset MCTD by measuring the kJX ratios and im- 
tered in a number of autoimmune diseases (5-8)* InSLE, tnunoglobulin concentrations in patients with this dis- 
the k/X ratio of total serum immunoglobulins is raised ease. The aim of the study was to find out whether these 
and in Sjogren’s syndrome, light chain restriction is found parameters were also disturbed in juvenile onset MCTD 
in parotid tissue (5). Abnormal kA  ratios have also been which might cast some light on the immune disorder un­
derlying this disease. The k/X ratio of total serum immu­
noglobulins reflects primarily the most abundant immu­
noglobulin in serum, usually IgG. Consequently, abnor­
malities in the light chain ratios of serum IgA and IgM
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Table I: Im munoglobulin G, A y and M  concentrations and light chain ratios in fourteen patients with juvenile onset M CTD compared to a reference 
group (14)
Concentration 
G/L (SD)
IgG
■IgA
IgM
Total
4-2,98,(±4,0),p =0,0012  
+ 0 .79 ,(± 1 .2 ) ,p=0.0114  
-0 .3 9 ,(± 0 .3 ) ,p=0.0002
k/A, ratio (SD)
+0.28, (±0.39), p=0.0016
+0.10,(±0.19), p=0.0732
-0.21, (±0.35), p = 0.0046
+0.20,(±0.35), p =0.0226
may be overshadowed. Therefore, we measured sepa­
rately the k/A ratios of polyclonal immunoglobulins G, 
A, and M in addition to the total k / X  ratio (13) as well as 
the serum concentration of the immunoglobulin isotypes 
G, A and M. These results were compared with those ob­
tained from 114 healthy children and 20 healthy adults 
(14).
PATIENTS AND METHODS
Patients
Fourteen patients, four boys and ten girls, diagnosed 
as having juvenile onset MCTD according to the classi­
fication of Kasukawa (2), were enrolled in the study. The 
clinical manifestations of the patients have been report­
ed earlier (4). At the time of blood sampling, their age 
ranged from 11.3 to 25 years with a median age of 21.8 
years. Seven patients were receiving regular treatment, 
either monotherapy or a combination of drugs (five cor­
ticosteroids, three hydroxychloroquine and three non- 
steroid anti-inflammatory drugs). Seven patients were 
without medication at the time of blood sampling.
Informed consent was obtained from parents or when 
appropriate from the patients. All blood samples were 
kept frozen until measured.
Methods
The immunoglobulin G, A, and M concentrations were 
measured by ELISA (13) and t h e  total k / X  ratio was mea­
sured by nephelometry using a n t i-K  and anti-A, antibod­
ies as described earlier (15), The k / X  ratios for each of 
the serum polyclonal immunoglobulin classes G, A, and 
M were measured by using a solid phase ELISA-sand- 
wich method (13). Affinity-purified goat antiserum di­
rected against human y, a  or ju, heavy chains was used to 
capture IgG, IgA or IgM, respectively. Peroxidase-
Dutch blood donors was measured at three different di­
lutions which were expected to lie at different points on 
the standard curve. The absorption was measured at 
492 nm and the concentration of the k  and A light chains 
was determined from a standard curve.
Statistical analyses
The results of the determination of IgG, IgA, and IgM 
concentration and of the separate k / X  ratios were com­
pared with the reference group of 134 healthy children 
and adults (14). All k / X  ratios as well as immunoglobu­
lin concentrations were corrected for age. Statistical anal­
ysis was done with the Wilcoxon test and a p value of 0.01 
was considered significant.
RESULTS
Comparing the patient group with the reference group, 
the mean concentration of serum IgG was 2.98 G/L 
(p=0.0012), higher and the mean IgG k / X  ratio was 0.28 
(p=0.0016) higher in the MCTD-group. The mean se­
rum IgA concentration was 0.79 G/L (p=0.0114) higher 
and the mean IgA k / X  ratio was 0.10 (p=0.0732) higher. 
In contrast, the mean concentration of serum IgM was 
0.39 G/L (p=0.0002) lower in the MCTD-group and the 
mean IgM k / X  ratio was 0.21 (p=0.0046) lower. The mean 
k / X  ratio of total serum immunoglobulins was 0,20 
(p=0,0226) higher in the MCTD-group as compared to 
that of the reference group (Table I).
DISCUSSION
The serum concentrations of IgG, IgA, and IgM were 
significantly altered in juvenile onset MCTD, Raised 
gammaglobulin levels have been reported earlier in this 
disease (16). This is due to a polyclonal activation of the
labelled goat anti-K or anti-A antiserum was used as a sec- B cell system prior to or during disease activity as not
ond antibody. As standard serum, pooled serum from 
500 healthy Dutch blood donors was used. As control se-
only anti-RNP antibodies were elevated but several oth­
er serum antibodies as well (17). The decreased serum
rum another batch of pooled serum from 500 healthy IgM concentration contrasts these findings. Apparent
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ly, the synthesis of the various is 
f ec ted .
s is differently af-
In patients with SLE, polyclonal activation of B cells 
is also present (18). In animal immunization experi­
ments, D N A  is poorly immunogenic; single-stranded 
DNA (ssDNA) elicits only a low titer antibody response, 
while double-stranded D N A  (dsDNA) is inactive (19). 
When the reacitivity of ssDNA of various mammalian 
and bacterial species origin was tested, patients with SLE 
demonstrated serum antibodies to all six types of DNA 
tested, whereas normal persons showed appreciable an­
tibody response only to D N A  obtained from certain bac­
teria (20,21). This implies that the response in patients 
with SLE is less specific than in healthy individuals. This
has not been studied in M CTD. In addition, antibodies
i
against bacterial D N A  are different in terms of heavy 
and light chain utilization in patients with SLE compared 
to normal individuals (21,22). This lends support to the 
suggestion that the anti-DNA antibodies in SLE patients 
may be a cross reaction, originally directed against an­
other antigen in a subject prone to polyclonal activation 
of the B cell system (20,23). As in SLE, polyclonal B cell 
activation is found in M C TD  (17). The hypothesis of 
cross-reactivity may therefore also apply for M CTD.
In the context of the cross reactions, the immunoglo­
bulin k /A  ratios are of particular interest. The total im­
munoglobulin k /A, ratio is altered in some autoimmune 
diseases (5-8,15), one of them being SLE with raised k/X 
ratio of total serum immunoglobulins (5), The antibod­
ies to DNA from the bacterium Micrococcus lysodeikth 
cus synthesized in normal subjects were primarily of the 
k  type (21). In contrast, antibodies to this bacterial D N A  
from SLE patients had more equivalent expression of k  
and A, chains (21). This indicates different immunologi­
cal processes in the reaction of SLE patients.
The k/X ratio of in vitro synthesized polyclonal immu­
noglobulins is lower in unstimulated cultures than after 
stimulation with phytohaemagglutinin (24). Light chain 
restricted response to certain antigens has also been dem ­
onstrated in animal studies and in humans, promoting 
either k  or X synthesis (25-27). Different light chain re­
actions for the various immunoglobulin isotypes direct- 
ed against the same antigen have even been demonstrat­
ed in vitro (27). This implies that the light chains are reg­
ulated differently according to the antigen stimulus. In 
our study, raised IgG concentration and IgG k/A  ratio 
and a decreased IgM concentration and IgM k/X ratio 
were found. This suggests that primarily the synthesis of 
K - b earing immunoglobulins is affected in juvenile onset 
MCTD, This may reflect a disturbed immune response 
or an antibody reaction, primarily provoked against a still 
unknown antigen. This light chain restricted antibody re­
action may be associated with T-cell imbalance as found 
in M CTD (28). Consequently, cross reaction of the pro­
duced antibodies would cause reaction against RNP in 
prone individuals. The effect of drug therapy on the light 
chain ratios has not been studied.
Earlier studies have also revealed antibodies directed 
against certain antigens to be of one light chain isotype 
whereas their reciprocal idiotypes were primarily of the 
o ther light chain type (29). This could also possibly be 
an explanation for the light chain restriction in juvenile 
onset MCTD.
We conclude that the altered concentration of the k/A, 
light chain ratios of IgG and IgM reflects an immune re-
v s p o n s e  originally directed against a still unknown anti­
gen. It may also be the consequence of an altered im­
mune response. This may result in abnormal antibody re­
action and subsequently cross reaction with RNP in pa­
tients with MCTD.
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